Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs
Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Lotilaner (Credelio™) is the newest member of the novel isoxazoline chemical class to be developed to treat canine ectoparasitism. Administered orally, lotilaner is rapidly absorbed with peak blood levels occurring within 2 h post-treatment. A study was undertaken to determine the earliest onset of lotilaner's efficacy against existing flea infesta...
Alternative Titles
Full title
Assessment of the onset of lotilaner (Credelio™) speed of kill of fleas on dogs
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8e1ab92aaca74a40aa97a66032a7ca67
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8e1ab92aaca74a40aa97a66032a7ca67
Other Identifiers
ISSN
1756-3305
E-ISSN
1756-3305
DOI
10.1186/s13071-017-2474-0
